These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26386345)

  • 21. Interactions of Antimicrobial Peptides with Bacterial Membranes and Membrane Components.
    Malmsten M
    Curr Top Med Chem; 2016; 16(1):16-24. PubMed ID: 26139113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A linguistic model for the rational design of antimicrobial peptides.
    Loose C; Jensen K; Rigoutsos I; Stephanopoulos G
    Nature; 2006 Oct; 443(7113):867-9. PubMed ID: 17051220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane targeting cationic antimicrobial peptides.
    Ciumac D; Gong H; Hu X; Lu JR
    J Colloid Interface Sci; 2019 Mar; 537():163-185. PubMed ID: 30439615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial peptides as an opportunity against bacterial diseases.
    Galdiero S; Falanga A; Berisio R; Grieco P; Morelli G; Galdiero M
    Curr Med Chem; 2015; 22(14):1665-77. PubMed ID: 25760092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of novel membrane active lipidated peptidomimetics active against drug resistant clinical isolates.
    Lohan S; Kalanta A; Sonkusre P; Cameotra SS; Bisht GS
    Bioorg Med Chem; 2014 Sep; 22(17):4544-52. PubMed ID: 25131957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane interaction and antibacterial properties of chensinin-1, an antimicrobial peptide with atypical structural features from the skin of Rana chensinensis.
    Shang D; Sun Y; Wang C; Wei S; Ma L; Sun L
    Appl Microbiol Biotechnol; 2012 Dec; 96(6):1551-60. PubMed ID: 22581068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.
    Kim H; Jang JH; Kim SC; Cho JH
    J Antimicrob Chemother; 2014 Jan; 69(1):121-32. PubMed ID: 23946320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria.
    Moravej H; Moravej Z; Yazdanparast M; Heiat M; Mirhosseini A; Moosazadeh Moghaddam M; Mirnejad R
    Microb Drug Resist; 2018; 24(6):747-767. PubMed ID: 29957118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The therapeutic applications of antimicrobial peptides (AMPs): a patent review.
    Kang HK; Kim C; Seo CH; Park Y
    J Microbiol; 2017 Jan; 55(1):1-12. PubMed ID: 28035594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational resources and tools for antimicrobial peptides.
    Liu S; Fan L; Sun J; Lao X; Zheng H
    J Pept Sci; 2017 Jan; 23(1):4-12. PubMed ID: 27966278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-Membrane Permeabilizing Modes of Action of Antimicrobial Peptides on Bacteria.
    Scocchi M; Mardirossian M; Runti G; Benincasa M
    Curr Top Med Chem; 2016; 16(1):76-88. PubMed ID: 26139115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial Peptides and their Pore/Ion Channel Properties in Neutralization of Pathogenic Microbes.
    Sharma S; Sahoo N; Bhunia A
    Curr Top Med Chem; 2016; 16(1):46-53. PubMed ID: 26139119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane Active Small Molecules Show Selective Broad Spectrum Antibacterial Activity with No Detectable Resistance and Eradicate Biofilms.
    Hoque J; Konai MM; Gonuguntla S; Manjunath GB; Samaddar S; Yarlagadda V; Haldar J
    J Med Chem; 2015 Jul; 58(14):5486-500. PubMed ID: 26102297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions.
    Gan BH; Gaynord J; Rowe SM; Deingruber T; Spring DR
    Chem Soc Rev; 2021 Jul; 50(13):7820-7880. PubMed ID: 34042120
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Lin S; Wade JD; Liu S
    Acc Chem Res; 2021 Jan; 54(1):104-119. PubMed ID: 33346639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic antimicrobial peptidomimetics with therapeutic potential.
    Haug BE; Stensen W; Kalaaji M; Rekdal Ø; Svendsen JS
    J Med Chem; 2008 Jul; 51(14):4306-14. PubMed ID: 18570363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Class of Cationic and Non-Peptidic Small Molecules as Hits for the Development of Antimicrobial Agents.
    Jiménez A; García P; de la Puente S; Madrona A; Camarasa MJ; Pérez-Pérez MJ; Quintela JC; García-Del Portillo F; San-Félix A
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29932141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
    Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
    J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational design of cationic antimicrobial peptides by the tandem of leucine-rich repeat.
    Ma QQ; Lv YF; Gu Y; Dong N; Li DS; Shan AS
    Amino Acids; 2013 Apr; 44(4):1215-24. PubMed ID: 23430306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial γ-AApeptides (WO2013112548): a patent evaluation.
    Teng P; Wu H; Lin L; Cai J
    Expert Opin Ther Pat; 2015 Jan; 25(1):111-8. PubMed ID: 25331592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.